CCM
RXDX

CAAS Capital Management’s Prometheus Biosciences, Inc. Common Stock RXDX Stock Holding History

CAAS Capital Management’s Portfolio RXDX Stock Details RXDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-15,000
Closed -$1.65M – 620
2022
Q4 		$1.65M Buy
+15,000
New +$1.65M 0.1% 51
2021
Q2 		– Sell
-15,000
Closed -$274K – 1058
2021
Q1 		$274K Buy
+15,000
New +$274K ﹤0.01% 611